Fousekis F.S., Papamichael K., Kourtis G., Albani E.N., Orfanidou A., Saridi M., Katsanos K.H., Christodoulou D.K. (2022)
The development of biological agents against tumor necrosis factor (TNF) has revolutionized the management of inflammatory bowel disease (IBD), frequently achieving induction and maintenance of remission in both ulcerative ...